TAO SHEN to China
This is a "connection" page, showing publications TAO SHEN has written about China.
Connection Strength
0.563
-
Surgical treatment versus observation in moderate intermittent exotropia (SOMIX): study protocol for a randomized controlled trial. Trials. 2023 Mar 01; 24(1):153.
Score: 0.184
-
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019 06; 156(8):2230-2241.e11.
Score: 0.139
-
Hepatitis B virus genotypes and genome characteristics in China. World J Gastroenterol. 2015 Jun 07; 21(21):6684-97.
Score: 0.108
-
Expert consensus on the bone repair strategy for osteoporotic fractures in China. Front Endocrinol (Lausanne). 2022; 13:989648.
Score: 0.045
-
CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017 May; 11(3):221-241.
Score: 0.031
-
Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay. BMC Infect Dis. 2016 Feb 01; 16:47.
Score: 0.028
-
Clinical Characteristics and Surgical Outcomes in Patients With Intermittent Exotropia: A Large Sample Study in South China. Medicine (Baltimore). 2016 Feb; 95(5):e2590.
Score: 0.028